Molecular characterization of CD44+/CD24-/Ck+/CD45- cells in benign and malignant breast lesions.

about

Molecular characterization of CD44+/CD24-/Ck+/CD45- cells in benign and malignant breast lesions.

Item

http://www.wikidata.org/entity/Q40367258

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Molecular characterization of ...... and malignant breast lesions.

@en

type

Item

label

Molecular characterization of ...... and malignant breast lesions.

@en

prefLabel

Molecular characterization of ...... and malignant breast lesions.

@en

P1476

Molecular characterization of ...... and malignant breast lesions.

@en

P2093

Alexandra Rêma

http://www.w3.org/2001/XMLSchema#string

Ana Helena Santos

http://www.w3.org/2001/XMLSchema#string

Ana Margarida Rosa

http://www.w3.org/2001/XMLSchema#string

Arnaud Da Cruz Paula

http://www.w3.org/2001/XMLSchema#string

Carlos Lopes

http://www.w3.org/2001/XMLSchema#string

Catarina Leitão

http://www.w3.org/2001/XMLSchema#string

Margarida Lima

http://www.w3.org/2001/XMLSchema#string

Maria de Fátima Faria

http://www.w3.org/2001/XMLSchema#string

Oriana Marques

http://www.w3.org/2001/XMLSchema#string

P2860

Vimentin is a novel AKT1 target mediating motility and invasion

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Breast cancer intra-tumor heterogeneity

Tumour evolution inferred by single-cell sequencing

Association of reactive oxygen species levels and radioresistance in cancer stem cells

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Diverse somatic mutation patterns and pathway alterations in human cancers

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

P2888

s00428-017-2068-4

P304

311-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00428-017-2068-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

470

http://www.w3.org/2001/XMLSchema#string

P50

Jose Luis Costa

Ana M Rocha

P577

2017-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1074199596

http://www.w3.org/2001/XMLSchema#string

P698

28116522

http://www.w3.org/2001/XMLSchema#string